Heparin crisis 2008: A tipping point for increased FDA enforcement in the pharma sector?

Food and Drug Law Journal

Volumn 65, Issue 3, 2010, Pages

  Rosania, Larry ^a  

^a IQVIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881394944     PISSN: 1064590X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Julie Schmit, Report: FDA So Underfunded, Consumers Are Put At Risk, USA Today, December 2, 2007, available at http://www.usatoday.com/news/washington/ 2007-12-02-fda-N.htm (last visited July 13, 2010).
2. Tufts Center for the Study of Drug Development, press release, New Approaches to R&D May Prove Best Path for Drug Developers, April 6, 2010, available at http://csdd.tufts.edu/news/complete-story/rd-pr-april-2010 (last visited July 13, 2010).
3. Steven Spear, Just-in-Time in practice at Toyota: Rules-in-Use for Building Self-Diagnostic, Adaptive Work-Systems, Working Paper, August 2002, available at http://www.hbs.edu/research/fac-pubs/workingpapers/papers2/0102/02- 043.doc (last visited July 13, 2010).
4. Patricia Van Arnum, Outsourcing Strategies of Emerging Pharma, Pharmaceutical Technology, October 2, 2008, available at http://pharmtech. findpharma.com/pharmtech/article/articleDetail.jsp?id=557186 (last visited July 13, 2010).
5. Patricia Van Arnum, Navigating the Global Pharmaceutical Supply Chain, Pharmaceutical Technology, March 2, 2010, available at http://pharmtech. findpharma.com/pharmtech/Ingredients+Insider/Navigating-the-Global- Pharmaceutical-Supply-Chain/ArticleStandard/Article/detail/660521 (last visited July 13, 2010).
6. Patricia Van Arnum, Best Practices in the Supply Chain, Pharmaceutical Technology, available at http://pharmtech.findpharma.com/pharmtech/Article/Best- Practices-in-the-Supply-Chain/ArticleStandard/Article/detail/601481 (last visited July 13, 2010).
7. Nikki Willett, Quality in the Global Pharmaceutical Supply Chain, Pharmaceutical Formulation & Quality, February/March 2010, available at: http://pharmaquality.com/ME2/Audiences/dirmod.asp?sid= 325598564E8C4B3EB736C7159241312D&nm=Browse+Articles&type= Publishing&mod=Publications%3A%3AArticle&mid= D3E3C719D8D44216836DCA4F4144BEC4&tier=4&id= 5EF71F0E39E44CABA65123BCCBE1EA0A&AudID=5648A5C28C97462DBBDB309539B820EF (last visited July 13, 2010).
8. Ruoyan Gai et al, GMP implementation in China: A double-edged sword for the pharmaceutical industry, Drug Discoveries & Therapeutics 2007; 1(1):12-13, available at http://www.ddtjournal.com/action/downloaddoc.php?docid= 20 (last visited July 13, 2010).
9. Carla Reed, Weak Links: A recent survey suggests that manufacturers don't have as much control over supply chain security as they think they do, Pharmaceutical Manufacturing, 2008, available at: http://www. pharmamanufacturing.com/articles/2008/115.html (last visited July 13, 2010).
10. David K. Cundiff, Letter-to-the Editor of the Journal of General Internal Medicine, January 2002, available at http://resources.metapress.com/pdf- preview.axd?code=d81201t603284876&size=largest (last visited July 13, 2010).
11. J.M. Walenga and Craig M. Jackson, Heparin and Low Molecular Weight Heparins: Safety of Heparin Biosimilars, webinar available at http://www.natfonline.org/docs/heparinwebinar.pdf (last visited July 13, 2010).
12. Steve Usdin, The Heparin Story, BioCentury, February 23, 2009, available at http://www.momentapharma.com/HeparinBIOCentury.pdf (last visited June 8, 2010) and http://www.biocentury.com/biotech-pharma-news/regulation/2009-02-23/ cover-story-regulation-the-heparin-story-a1 (last visited July 13, 2010).
13. Anon, March 2008, Heparin Crisis Rekindles Concern About Disease From Pig Transplants, available at http://www.animalpeoplenews.org/08/3/ heparincrisisrekindlesconcern0308.htm (last visited July 13, 2010).
14. Alicia Mundy, FDA Faulted in Heparin Case, Wall Street Journal, April 29, 2010, available at http://online.wsj.com/article/ SB10001424052748703572504575214420823549694.html (last visited June 8, 2010).
15. Gordon Gibb, Heparin Counterfeit Seven Times Cheaper than the Real Thing, LawyersandSettlements.com, April 15 2008, available at http://www. lawyersandsettlements.com/articles/10432/heparin-counterfeit-cheaper.html (last visited July 13, 2010).
16. Susan Briones, Heparin Recall: Another Crisis for China & the FDA , University of Houston Health Law Perspectives, available at http://www.law.uh. edu/healthlaw/perspectives/2008/(SB)%20heparin.pdf (last visited July 13, 2010).
17. G. Turabelidse et al, Acute Allergic-Type Reactions Among Patients Undergoing Hemodialysis - Multiple States, 2007-2008, Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report, February 1, 2008, available at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm57e201a1.htm (last visited July 13, 2010).
18. Animal People, March 2008, Heparin Crisis Rekindles Concern About Disease From Pig Transplants, available at http://www.animalpeoplenews.org/08/3/ heparincrisisrekindlesconcern0308.htm (last visited June 8, 2010).
19. R. Sasisekharan & Z. Shriver, From Crisis to Opportunity: A Perspective on the Heparin Crisis, Thromb Haemost 102(5):854-8 (2009), available at http://pubget.com/paper/19888519 (last visited June 8, 2010).
20. Susan Briones, Heparin Recall: Another Crisis for China & the FDA, Health Law Perspectives (April 2008), available at http://www.law.uh.edu/ Healthlaw/perspectives/2008/(SB)%20heparin.pdf (last visited June 8, 2010).
21. U.S. Food and Drug Administration press release, Baxter's Multiple-dose Vial Heparin Linked to Severe Allergic Reactions: FDA advises health care practitioners to switch suppliers and limit use of drug until problem identified (February 11, 2008), available at http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/2008/ucm116858.htm (last visited June 8, 2010).
22. Steve Usdin, The Heparin Story, BioCentury, February 23, 2009, available at http://www.momentapharma.com/HeparinBIOCentury.pdf (last visited June 8, 2010).
23. R. Sasisekharan & Z. Shriver, From Crisis to Opportunity: A Perspective on the Heparin Crisis, Thromb Haemost 102(5):854-8 (2009).
24. U.S. Food and Drug Administration Information on Heparin Update: Follow up to the Public Health Alert about Changes to the Heparin Sodium USP Monograph (April 7, 2010), available at http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm112597.htm (last visited June 8, 2010).
25. Alicia Mundy, FDA Withholds List of Chinese Heparin Suppliers From Probe by Congress, Wall Street Journal, May 10, 2008, available at http://www.mindfully.org/Health/2008/FDA-Chinese-Heparin10may08.htm (last visited June 8, 2010).
26. Animal People, March 2008, Heparin Crisis Rekindles Concern About Disease From Pig Transplants.
27. A. Stanley, P. Thomas, M.V. Wagner & E. Ciurczak, Lessons from Heparin, PharmaManufacturing.com, available at http://www.pharmamanufacturing. com/articles/2008/123.html (last visited June 8, 2010).
28. FDA Warning Letter, April 2008, available at http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/ EnforcementActivitiesbyFDA/ WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/ucm054109. pdf (last visited July 13, 2010).
29. Alicia Mundy, FDA Withholds List of Chinese Heparin Suppliers From Probe by Congress, Wall Street Journal, May 10, 2008.
30. Political Transcript Wire, House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations Holds a Hearing on Heparin (April 29, 2008), available at http://findarticles.com/p/news-articles/political- transcript-wire/mi-8167/is-20080430/rep-bart-stupak-holds-hearing/ai-n50727255/ (last visited June 8, 2010).
31. Gardiner Harris & Walt Bogdanich, F.D.A. Broke Its Rules by Not Inspecting Chinese Plaint with Problem Drug, New York Times (Feb. 15, 2008), available at http://www.nytimes.com/2008/02/15/washington/15fda.html (last visited June 8, 2010).
32. Susan Briones, Heparin Recall: Another Crisis for China & the FDA, University of Houston Health Law Perspectives.
33. Alicia Mundy, FDA Faulted in Heparin Case, Wall Street Journal, April 29, 2010.
34. House Energy and Commerce Committee Republicans press release, Congressmen reveal credible leads in contamination case (April 30, 2010), available at http://republicans.energycommerce.house.gov/News/PRArticle.aspx? NewsID=7832 (last visited June 8, 2010).
35. House Committee on Energy and Commerce letter to FDA Commissioner Margaret A. Hamburg (April 30, 2010), available at http://Republicans. EnergyCommerce.house.gov/Media/file/News/043010-Letter-to-FDA-Heparin.pdf (last visited June 8, 2010).
36. FDA News Release, FDA Alert: New USP Standards for Heparin Products Will Result in Decreased Potency Adjustments may be needed to achieve desired anticoagulant effect in some patients New Heparin to Ship Starting October 8 (October 1, 2009), available at http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm184674.htm (last visited June 8, 2010).
37. Eric Lipton, With Obama, Regulations Are Back in Fashion, New York Times, May 12, 2010, available at http://www.nytimes.com/2010/05/13/us/politics/ 13rules.html (last visited June 8, 2010).
38. FDA Enforcement Statistics, Chapter 10, page 10-5, available at http://www.fda.gov/downloads/ICECI/EnforcementActions/EnforcementStory/ UCM129823.pdf (last visited June 9, 2010).
39. CNN report, U.S. opens food safety office in China after scares, available at http://www.cnn.com/2008/WORLD/asiapcf/11/19/china.fda.poisoned/ index.html (last visited June 9, 2010).
40. Department of Health and Human Services press release, HHS Preparing to Open FDA Offices in China, India, Europe, and Latin America This Year, October 16, 2008, available at http://www.hhs.gov/news/press/2008pres/10/20081016a.html (last visited June 9, 2010).
41. Text of H.R. 759: Food and Drug Administration Globalization Act of 2009, available at http://www.govtrack.us/congress/billtext.xpd?bill=h111-759 (last visited June 8, 2010).
42. Bill Text 111th Congress (2009-10), H.R. 759.IH, Section 741: Facility Registration Fee, available at http://thomas.loc.gov/cgi-bin/query/F?c111:1:./ temp/~c111nA2KxP:e7663: (last visited July 13, 2010).
43. Bill Text 111th Congress (2009-10), H.R. 759.IH, Section 202: Inspection of producers of drugs and active pharmaceutical ingredients, available at http://thomas.loc.gov/cgi-bin/query/F?c111:1:./temp/~c111z3EVN1:e110303: (last visited July 13, 2010).
44. Maribel Rios, Congress Introduces FDA Globalization Act of 2009, Pharmaceutical Technology, February 12, 2009, available at http://pharmtech. findpharma.com/pharmtech/Ingredients/Congress-Introduces-FDA-Globalization-Act- of-- 2009/ArticleStandard/Article/detail/580861 (last visited June 8, 2010).
45. Christina Graffner, Swedish Medical Products Agency, Workshop: Quality by Design in pharmaceutical development and manufacture, March 28, 2006, available at http://www.ema.europa.eu/Inspections/docs/Presentations/SEMPA- ICHQ8PharmaceuticalDevelopment.pdf (last visited July 13, 2010).
46. inPharmaTechnologist.com, FDA launches QbD pilot programme, available at http://www.inpharmatechnologist.com/Industry-Drivers/FDA-launches-QbD-pilot- programme (last visited June 9, 2010).
47. FDA report, Pharmaceutical cGMPS for the 21st Century - A Risk-Based Approach: Second Progress Report and Implementation Plan Introduction, February 20, 2003, available at http://www.fda.gov/cder/gmp/gmp2004/GMP-finalreport2004. htm (last visited June 9, 2010).
48. Federal Register, July 2, 2008, available at http://www.fda.gov/OHRMS/ DOCKETS/98fr/E8-14999.htm (last visited June 8, 2010).
49. inPharmaTechnologist, FDA enlarges and extends QbD pilot programme, September 22, 2009, available at http://www.in- pharmatechnologist.com/ Processing-QC/FDA-enlarges-and-extends-QbD-pilot-programme (last visited June 9, 2010).
50. Bettina Wassener, In China, Strong Debut for Supplier of Heparin, New York Times, May 6, 2010, available at http://www.nytimes.com/2010/05/07/ business/global/07drug.html (last visited June 9, 2010).
51. FDA publication, Heparin: Change in Reference Standard, April 7, 2010, available at http://www.fda.gov/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucm184687.htm (last visited June 9, 2010).
52. Robert F. Church & Michael N. Druckman of Hogan & Hartson, Is FDA Getting Back to Basics? Recent Trends in FDA's Pharmaceutical GMP and GCP Enforcement, Webinar, May 19, 2009, available at http://www.hoganlovells.com/ files/Event/6e33298e-519b-4bd6-9b04-b1d681073a1e/Presentation/EventAttachment/ ddbe4504-f8e2-4a09-9d88-9dnb27c71ad/FDA-051909.pdf (last visited June 9, 2010).
53. Food and Drug Administration Fiscal Year (FY) 2008 Enforcement Statistics Summary, available at http://www.fda.gov/downloads/ICECI/EnforcementActions/ EnforcementStory/UCM129824.pdf.
54. Food and Drug Administration News Release, President's FY 2010 Budget for FDA Invests Substantially in Food and Medical Product Safety, May 7, 2009, available at http://www.fda.gov/News-Events/Newsroom/PressAnnouncements/2009/ ucm152276.htm (last visited July 13, 2010).
55. Letter from FDA Commissioner Margaret A. Hamburg to Senator Charles E. Grassley, March 4, 2010, available at http://grassley.senate.gov/about/upload/ FDA-3-4-10-Hamburg-letter-to-Grassley-re-GAO-report-on-OCI.pdf (last visited June 9, 2010).